InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Thomas John C, Director. Director active across 1 companies, notably Virios Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Total volume traded: €10k. The latest transaction was filed on 4 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€4,9991,000 shares@ €4.999100.0% of flow
Common Stock
SEC:0001415889-22-000165·
Ideal exit: 1 Oct 2022 (T+270)
€4,9991,000 shares@ €4.99950.0% of flow
Common Stock
SEC:0001415889-22-000165:0·
Ideal exit: 1 Oct 2022 (T+270)
2 of 2 declarations
About Thomas John C
John C. Thomas is a Board Member of Virios Therapeutics, Inc. In this role, he contributes to the governance of the company and to strategic decision-making. His experience in the biopharmaceutical sector allows him to provide valuable insights during board discussions. John Thomas is committed to supporting the mission of Virios Therapeutics.
